Dr. rer. nat. Stephanie Stölting

  • Functional relevance of nexilin in dilated cardiomyopathy and systolic dysfunction
  • Protein-protein interactions in disease

2013 – ongoing

Post doc (part time) Institute for Integrative and Experimental Genomics at the r University of Lübeck

2012 – 2012

Post doc (part time) Medizinische Klinik II, UKSH Lübeck

2009 – 2011

Freelance consultant for tissue removal authorization

2006 – 2008

Quality management representative HÄLSA Pharma (DiapharmGruppe) a representative for medical devices (part time)

 2005 – 2008

Projectmanagement DiapharmGruppe with the main focus certification of biotechnolgical products, in- vitro diagnostica and pharmaceutical medical devices (part time)

2003 – 2005

Consultant DiapharmGruppe with the main focus certification of biotechnological products and in- vitro diagnostic (part time)

2002 – ongoing

Postdoc (part time) Department of hematology and oncology, Medizinische Klinik I, UKSH Lübeck

1998 – 2002

Phd thesis Medizinische Klinik II, Universitätsklinikum Lübeck

Titel: Charakterisierung des Myosinbindeproteins-C in Embryoid Bodies anhand von „Knock-in“- und „Knock-out“-Mutationen

1998 – 1998

Scientific participation at the lab for transport protein research of Dr. H. Jung, University of Osnabrück

1997 – 1998

Diploma thesis at the lab for transport protein research of Dr. H. Jung, University of Osnabrück

  • Deutsches Zentrum für Herz-Kreislauf Forschung e.V. (DZHK)

Pharmaceutical industry

Funding Period: 2007-2013
Amount: 90.000,–€

Foundations

Funding Period: 2012-2014
Amount: 10.000,–€
Scroll to Top